It's natural to want a number. But honest expectations matter more than hype, here's a grounded look at what GLP-1 weight loss realistically looks like, without the marketing gloss.
Any program promising a specific amount of weight loss in a specific timeframe is overpromising. Results vary genuinely from person to person based on biology, starting point, dose, consistency, and lifestyle. Honest guidance talks in ranges and individual variation, not guarantees.
Key point: 'Results vary' isn't a disclaimer to skip past, it's the actual truth of how these medications work across different people.
Clinical research on FDA-approved brand-name GLP-1 medications (not compounded versions) reports average weight loss, and those averages are meaningful: for example, 14.9% over 68 weeks with semaglutide 2.4 mg in STEP 1[1] and up to 20.9% over 72 weeks with tirzepatide in SURMOUNT-1.[2] But an average is not a promise for any one person. Some people respond strongly, others more modestly. Comparing yourself to someone else's result, or to a headline average, usually isn't useful.
Answer six quick questions and we'll match you to a LegitScript-certified, physician-led program suited to your situation.
Take the QuizSteady, sustainable progress beats chasing a fast number. The people with the best long-term outcomes treat GLP-1 as a tool paired with habits, stay consistent, and measure success over months, not days.
Important: This is general education. Your physician can give you a realistic picture for your specific situation, which is far more useful than any general figure.
Take the 60-second quiz and we'll match you to the LegitScript-certified program most likely to fit your needs.
Take the Quiz, 60 SecondsAbout these figures: The clinical trial results cited on this page reflect the safety and efficacy of the FDA-approved brand-name medications that were studied (such as Wegovy®, Zepbound® and Foundayo™), used alongside a reduced-calorie diet and physical activity under clinical-trial conditions. Compounded medications do not undergo FDA evaluation for safety or effectiveness and were not studied in these trials; their efficacy and safety profiles may differ from the brand-name medications studied. Individual results vary. This information is educational and is not medical advice.
Price changes, new program reviews, and plain-English GLP-1 updates, straight to your inbox. Independent, and never sponsored by the programs we review.
By joining, you agree to receive emails from GLP One Guide. Unsubscribe anytime. We never sell your email. See our Privacy Policy.